IMPEDIMED LIMITED — Capital/Financing Update 2011

Jan 27, 2011

==> picture [81 x 92] intentionally omitted <==

27 January 2011

Australian Securities Exchange Announcement

NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES OR TO US PERSONS

IMPEDIMED RAISES A$4.27 MILLION UNDER SHARE PURCHASE PLAN

Brisbane, Australia. – ImpediMed Limited (“ ImpediMed ” or the “ Company ”) refers to recent announcements regarding its Share Purchase Plan (“ SPP ”) which closed on Monday 24 January 2011. ImpediMed is pleased to announce that it has successfully raised A$4.27 million (before costs) under the SPP.

All valid applications have been accepted in full.

The SPP was underwritten by Wilson HTM and RBS Morgans (the “Underwriters”) up to a maximum of A$4.27 million. Accordingly, the Company will not place any shares with the Underwriters.

In accordance with the revised timetable announced by ImpediMed on 13 January 2011, the SPP shares are expected to be issued tomorrow (28 January 2011) with trading in these shares expected to commence on Monday 31 January 2011.

Enquiries about the SPP should be directed to ImpediMed’s CEO, Greg Brown, on +61 7 3860 3700.

ENDS

NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES

This announcement has been prepared for publication in Australia and may not be distributed or released in the United States. This announcement does not constitute an offer of shares for sale in the United States or in any other jurisdiction in which such an offer would be illegal. The new shares the subject of the SPP have not been, and will not be, registered under the US Securities Act of 1933 and, accordingly, may not be offered or sold in the United States except in transactions exempt from, or not subject to, the registration requirements of such Act and applicable US state securities laws.

The securities to be issued under the SPP have not been, and will not be, registered under the US Securities Act of 1933. Securities may not be offered or sold in the United States or to US persons unless the securities have been registered under the Securities Act or an exemption from registration is available.

ASX CODE: IPD

In Australia: ImpediMed Limited Unit 1, 50 Parker Court Pinkenba, QLD 4008 Phone : +61-7-3860-3700

ImpediMed Limited ABN 47 106 092 577 Website: www.impedimed.com